An Unliganded Thyroid Hormone β Receptor Activates the Cyclin D1/Cyclin-Dependent Kinase/Retinoblastoma/E2F Pathway and Induces Pituitary Tumorigenesis
Open Access
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 25 (1) , 124-135
Abstract
Thyroid-stimulating hormone (TSH)-secreting tumors (TSH-omas) are pituitary tumors that constitutively secrete TSH. The molecular genetics underlying this abnormality are not known. We discovered that a knockin mouse harboring a mutated thyroid hormone receptor (TR) β (PV; TRβPV/PV mouse) spontaneously developed TSH-omas. TRβPV/PV mice lost the negative feedback regulation with highly elevated TSH levels associated with increased thyroid hormone levels (3,3′,5-triiodo-l-thyronine [T3]). Remarkably, we found that mice deficient in all TRs (TRα1−/−TRβ−/−) had similarly increased T3 and TSH levels, but no discernible TSH-omas, indicating that the dysregulation of the pituitary-thyroid axis alone is not sufficient to induce TSH-omas. Comparison of gene expression profiles by cDNA microarrays identified overexpression of cyclin D1 mRNA in TRβPV/PV but not in TRα1−/−TRβ−/− mice. Overexpression of cyclin D1 protein led to activation of the cyclin D1/cyclin-dependent kinase/retinoblastoma protein/E2F pathway only in TRβPV/PV mice. The liganded TRβ repressed cyclin D1 expression via tethering to the cyclin D1 promoter through binding to the cyclic AMP response element-binding protein. That repression effect was lost in mutant PV, thereby resulting in constitutive activation of cyclin D1 in TRβPV/PV mice. The present study revealed a novel molecular mechanism by which an unliganded TRβ mutant acts to contribute to pituitary tumorigenesis in vivo and provided mechanistic insights into the understanding of pathogenesis of TSH-omas in patients.Keywords
This publication has 36 references indexed in Scilit:
- The activities of cyclin D1 that drive tumorigenesisTrends in Molecular Medicine, 2004
- Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actionsMolecular and Cellular Endocrinology, 2003
- Somatic Mutation of TR Can Cause a Defect in Negative Regulation of TSH in a TSH-Secreting Pituitary TumorThe Journal of Clinical Endocrinology & Metabolism, 2001
- Aberrant Alternative Splicing of Thyroid Hormone Receptor in a TSH-Secreting Pituitary Tumor Is A Mechanism for Hormone ResistanceMolecular Endocrinology, 2001
- A Pituitary Tumor in a Patient with Thyroid Hormone Resistance: A Diagnostic DilemmaThyroid®, 2001
- Mechanisms That Mediate Negative Regulation of the Thyroid-stimulating Hormone α Gene by the Thyroid Hormone ReceptorJournal of Biological Chemistry, 1999
- Thyrotropin-Secreting Pituitary Tumors: Diagnostic Criteria, Thyroid Hormone Sensitivity, and Treatment Outcome in 25 Patients Followed at the National Institutes of HealthThe Journal of Clinical Endocrinology & Metabolism, 1999
- Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressorNature, 1995
- Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndromeMolecular Endocrinology, 1994
- Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.Journal of Clinical Investigation, 1991